Synaptogenix Inc (SNPX)

[runncoach]

SIB improvement of 1.5 which is better than the current FDA drug. Worst side effect was increase in diarrhea. Company still going through data. No way of us telling from the results so far in the PR if half responded in really big way or if improvement was universal improvement of 1.5. No doubt the drug worked and no doubt it moves forward from here to next trial. Congrats to Dr Alkon and the company. Hoping investor call is informative regardless of how this will be spun by AF and that crew.